|
|
Prostate
|
|
Organ |
Sex |
Age |
Pathologic diagnosis |
Grade |
|
|
prostate |
M |
58 |
hyperplasia |
|
|
|
M |
72 |
atypical hyperplasia |
|
|
|
M |
41 |
Normal |
|
|
|
M |
67 |
squamous carcinoma |
Ⅱ |
|
|
M |
53 |
transitional cell carcinoma |
Ⅱ |
|
|
M |
77 |
adenocarcinoma |
|
|
|
M |
48 |
adenocarcinoma |
Ⅰ |
|
|
M |
59 |
adenocarcinoma |
Ⅱ |
|
|
M |
50 |
adenocarcinoma |
Ⅲ |
|
|
M |
75 |
adenocarcinoma |
Ⅲ |
|
|
M |
53 |
adenocarcinoma |
|
|
|
M |
71 |
papillary adenocarcinoma |
Ⅰ |
|
|
M |
63 |
mucinous adenocarcinoma |
Ⅱ |
|
|
M |
51 |
mucinous adenocarcinoma |
Ⅲ |
|
|
M |
73 |
acinic cell carcinoma |
|
|
|
M |
50 |
neurinoma |
|
|
|
M |
50 |
carcinoid |
|
|
|
M |
39 |
anaplastic carcinoma |
Ⅲ |
|
|
M |
52 |
malignant angiosarcoma |
|
|
|
M |
63 |
leiomyosarcoma |
|
|
|
M |
38 |
adenosarcorhabdomyoma |
|
|
|
M |
49 |
sarcoma epithelioides |
Ⅰ |
|
|
M |
51 |
dysembryoma |
|
|
|
M |
40 |
metastatic carcinoma |
|
|
|
M |
28 |
metastatic carcinoma |
|
|
|
M |
56 |
lymphaden metabasis |
Ⅲ |
|
|
M |
63 |
inflammation |
|
|
|
 |